Product/Composition:- | Lamivudine & Zidovudine |
---|---|
Strength:- | Lamivudine 150 mg + Zidovudine 300 mg |
Form:- | Tablet |
Reference Brands:- | Combivir®(US/ EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Lamivudine & Zidovudine Tablets (150 mg/300 mg) offer a fixed-dose antiretroviral for HIV treatment. Available through PharmaB2B from certified manufacturers, it's ideal for tenders, NGOs, and hospital procurement. Ensure compliant, bulk sourcing from WHO-GMP and USFDA-approved suppliers to support reliable HIV therapy access globally.
Lamivudine & Zidovudine Tablets are a fixed-dose combination of two key NRTIs used in the management of HIV-1 infection. Each tablet contains Lamivudine 150 mg and Zidovudine 300 mg, offering dual-action antiviral activity in a convenient dosing format. Available under brands like Combivir®, this formulation is widely used in global HIV treatment protocols. Through PharmaB2B platforms, healthcare providers and procurement agencies can access bulk supplies from WHO-GMP and USFDA-approved manufacturers. Ideal for tenders, NGOs, and institutional buyers, this ARV combo supports consistent, cost-effective treatment. Connect with trusted suppliers to ensure high-quality antiretrovirals and uninterrupted patient care.